Issues

Home > Issues (Page 23)

June 23, 2020 Coronavirus

Dr. Henry Miller talks about dangers from the United States sourcing a majority of active pharmaceutical ingredients, commonly called APIs, from China and other places impacted by the coronavirus, or COVID-19, pandemic. APIs can be considered the "important" component of a pill or medicine. Miller references a 2019 report by the U.S.-China Economic and Security Review Commission that highlights the growing reliance on China for APIs and problems with China's regulatory and quality control standards. Miller says more oversight and regulation...

June 18, 2020 Blog, Industry Trends

By: Kathleen Hefferon, Ph.D., and Henry Miller, M.S., M.D. COVID-19 has turned our world upside down in so many ways, and the food supply chain is no exception. Whether consumers prefer fast or slow food, meat-based or vegan, local or imported, organic or conventional, supermarkets or farmers’ markets, every aspect of our food supply chain, from farm to fork, has been affected by this scourge. The recent, rampant outbreaks of COVID-19 among meat-processing workers – over the past month or so, the...

June 17, 2020 Infographics, Price and Costs

 The Professor and Pete reach the most difficult part of their journey: understanding how medicines are sold. It’s a complex system that hurts patients and at times exposes them to paying excessive costs. They also learn that patients who get their prescriptions from a pharmacy don’t really benefit from drug discounts negotiated by pharmacy benefit managers (PBMs) – only PBMs and insurers do....

June 15, 2020 Blog, Coronavirus, Coronavirus - Alternate

By Andrew I. Fillat and Henry I. Miller With the world in the grip of the COVID-19 pandemic, most of the short-term focus is now on how to avoid surges of infections and get the economy functioning so people can go back to work. Hindsight is, of course, 20-20. Many lessons about pandemics will be learned in retrospect—the most notable being the need for epidemiological surveillance, preparedness with stockpiles of medical supplies, and how not to handle the most vulnerable population during...

June 14, 2020 Coronavirus

By: Henry Miller and Jeff Stier The World Health Organization this week showed once again why the motto on its official seal should be, Aperto Ore, Pede Inserta, or in English: Open Mouth, Insert Foot. On Monday, Dr. Maria Van Kerkhove, head of the WHO's emerging disease and zoonosis unit, said that transmission of COVID-19 from asymptomatic, infected patients to other persons was "very rare." There was immediate and widespread pushback. For example, on Tuesday the Harvard Global Health Institute issued a...

June 14, 2020 Coronavirus

Dr. Henry Miller joins the John Batchelor Show to discuss the release of two studies measuring the impact of infections and deaths due to the coronavirus. A Berkeley study said that the shutdowns could have prevented 120 million novel coronavirus infections in the United States, and about 600 million in China. The other study, from the Imperial College London, 3.1 million lives across 11 European countries, shutdowns dropped infection rates by an average of 82 percent. Miller and John Batchelor also...

June 12, 2020 Coronavirus

Dr. Henry Miller, M.S., M.D., and PRI's Senior Fellow with PRI, talks about the many missteps of the World Health Organization (WHO), including the recent confusion about the transmission of the coronavirus or COVID-19. Miller and Lars Larson also discuss funding for WHO, how doctors and researchers are selected, and problems with how the organization is run and funded. Lars Larson National Podcast · Lars Larson National Podcast 06-09-20...

June 8, 2020 Coronavirus

Our previous article described some of the bizarre speculations and conspiracy theories circulating about the COVID-19 pandemic—ranging from the more or less plausible, but unproven, to the absurd. Many of them, such as 5G networks supposedly spreading infections or the pandemic having been concocted to promote tyrannical, world governance, are easily dismissed, but are still being widely circulated on social media. What's more, it appears that much of the disinformation has arisen not just from domestic, garden-variety kooks and conspiracy theorists, but...

June 3, 2020 Blog, Coronavirus

Dr. Henry Miller joins the Lars Larson Show for his weekly update on the coronavirus pandemic and COVID-19. Larson and Dr. Miller look at the impact and potential threats of the spread of COVID-19 due to the unrest in cities around the United States and why PPE equipment and social distancing measures have fallen by the wayside. Lars Larson National Podcast · Lars Larson National Podcast 06-02-20...

June 2, 2020 Blog, Coronavirus

As the COVID-19 epidemic drags on with no end in sight, the U.S. economy in tatters, and “reopening” going haltingly, many observers have come to the realization that we might need to learn to “live with the virus”—meaning with ongoing new infections—until a vaccine is available. Thus, there is an understandable hunger for one, and some 95 vaccines to prevent COVID-19 are now in various stages of development. Some of the reports of progress on this front have been encouraging, and there is...

May 28, 2020 Coronavirus, Issues

By Henry I. Miller, M.S., M.D. and Andrew I. Fillat ‘Metadata” might sound like something that “Star Trek‘s” Spock would oversee, but it is real and increasingly familiar, as the result of stories about wiretaps and security. The easiest-to-understand example of it is information about the time, duration, originating number, and destination number of a phone call – but without any of the content (i.e. words spoken) of the call. Metadata might also indicate from its format that a field on a...

May 27, 2020 Coronavirus, Coronavirus Multimedia, Industry Trends, Infographics, Innovation, Radio

Listen to Dr. Henry Miller, PRI senior fellow in health studies, discuss the move by the WHO to pause hydroxychloroquine trials for Coronavirus treatment on the nationally-syndicated Lars Larson Show. TheLarsLarsonShow · Dr. Henry Miller - WHO pauses hydroxychloroquine trials for Coronavirus treatment...

May 27, 2020 Blog, Coronavirus, Policy Proposals

By Henry I. Miller, M.S., M.D. and Andrew I. Fillat Every day seems to bring some new, unexpected, unpleasant revelation about the SARS-CoV-2 and the illness it causes, COVID-19. The infection has a long, often asymptomatic incubation period, high transmissibility, the ability to infect many human tissues, and, frequently, rapid deterioration of the clinical course. Some curious aspects of the infection, such as long duration of symptoms, multi-organ involvement, blood clots, and patients’ ability to tolerate extremely low blood oxygen levels have...

May 26, 2020 Blog, Coronavirus, Policy Proposals

America is in a state of collective angst, one that hasn't been seen since perhaps the Second World War. Every crisis since then, whether it was war, the 9/11 attacks, flu pandemics, or financial meltdown, had left most Americans unaffected. But now, few are economically, medically, or emotionally untouched. The SARS-CoV-2 virus and the disease it causes, COVID-19, pose threats or extreme inconvenience of one sort or another to virtually everyone. In a crisis like this, driven by health (and the...

May 21, 2020 Issues, Price and Costs

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column width="2/3"][vc_column_text css=".vc_custom_1590107672986{padding-right: 40px !important;}"]DOWNLOAD THE PDF In October 2019, the Center for Medical Economics and Innovation at the Pacific Research Institute, under the direction of Dr. Wayne Winegarden, released its second study documenting the savings potential enabled by biosimilars. Biosimilars are medicines manufactured in, or derived from, biological sources that are developed to be similar to FDA-approved reference products. Biosimilars are only approved to compete in nine biologic drug classes in the U.S....

May 20, 2020 Coronavirus, Innovation

A COVID-19 Vaccine by January? Here’s Why It’s Possible But Not Likely By Christopher Curley The timeline to develop a safe, effective vaccine to fight a virus is typically counted in years — or even decades. But with the COVID-19 pandemic affecting millions around the world and killing hundreds of thousands of people, the race is on to produce a vaccine faster than ever before. President Donald Trump has said a vaccine could be available by January, which would be an unprecedented development cycle. But how realistic is that? Experts...

May 19, 2020 Coronavirus

As the COVID-19 epidemic drags on with no end in sight, the U.S. economy in tatters, and “reopening” going haltingly, many observers have come to the realization that we might need to learn to “live with the virus”—meaning with ongoing new infections—until a vaccine is available. Expecting a coronavirus vaccine in the near future may be the triumph of hope over experience. Thus, there is an understandable hunger for one, and some 95 vaccines to prevent COVID-19 are now in various stages...